scholarly article | Q13442814 |
P50 | author | Nicolaus Kröger | Q86950236 |
P2093 | author name string | Maximilian Christopeit | |
Francis Ayuk | |||
Christine Wolschke | |||
Dietlinde Janson | |||
Ute-Marie von Pein | |||
Franziska Modemann | |||
P2860 | cites work | Graft-versus-host disease: why have we not made more progress? | Q27012940 |
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis | Q33399980 | ||
Managing side effects of JAK inhibitors for myelofibrosis in clinical practice | Q33442340 | ||
How I treat refractory acute GVHD. | Q35828633 | ||
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey | Q36862931 | ||
Interleukin-2 and regulatory T cells in graft-versus-host disease | Q37055805 | ||
Classification systems for chronic graft-versus-host disease. | Q39002161 | ||
Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects | Q40936847 | ||
Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation | Q43494585 | ||
The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia. | Q49384876 | ||
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy | Q49679320 | ||
Advance in Targeted Immunotherapy for Graft-Versus-Host Disease. | Q54937398 | ||
Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells-Single Center Experience | Q57174876 | ||
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study | Q58610776 | ||
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease | Q87635679 | ||
Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation | Q88815098 | ||
"Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway | Q90952392 | ||
P921 | main subject | ruxolitinib | Q7383611 |
stem cell transplantation | Q65592366 | ||
P577 | publication date | 2020-05-23 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level |
Q102141667 | Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease | cites work | P2860 |
Search more.